Detail akcie Boston Scient online

Business Summary: Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Boston Scientific Corporation revenues increased 12% to $14.24B. Net income applicable to common stockholders increased from $642M to $1.57B. Revenues reflect Cardiovascular segment increase of 13% to $8.82B, MedSurg segment increase of 10% to $5.42B, United States segment increase of 10% to $8.43B, EMEA (Europe, Middle East and Africa) segment increase of 13% to $2.86B.